1 "sgk is an aldosterone -induced kinase in the renal collecting duct" 274 : 16973-16978, 1999
2 "Volumes and Na/Hantiporter activity of lymphocytes in patients with congestive heart failure. Clin Invest 72" 985-991, 1994
3 "The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action" 142 : 1587-1594, 2001
4 "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators" 341 : 709-717, 1999
5 "Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production" 85 : 336-344, 2000
6 "Renin-angiotensin-aldosterone system and cardiovascular diseases" 19 : 551-572, 2004
7 "Remodeling of the right and left ventricles in experimental hypertension. Circ Res 67" 1355-1364, 1990
8 "Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma" 95 : 1471-1478, 1997
9 "Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells" 76 : 973-979, 1995
10 "Non-genomic action of the mineralocorticoid aldosterone on cytosolic sodium in cultured kidney cells" 511 : 255-263, 1998
1 "sgk is an aldosterone -induced kinase in the renal collecting duct" 274 : 16973-16978, 1999
2 "Volumes and Na/Hantiporter activity of lymphocytes in patients with congestive heart failure. Clin Invest 72" 985-991, 1994
3 "The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action" 142 : 1587-1594, 2001
4 "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators" 341 : 709-717, 1999
5 "Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production" 85 : 336-344, 2000
6 "Renin-angiotensin-aldosterone system and cardiovascular diseases" 19 : 551-572, 2004
7 "Remodeling of the right and left ventricles in experimental hypertension. Circ Res 67" 1355-1364, 1990
8 "Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma" 95 : 1471-1478, 1997
9 "Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells" 76 : 973-979, 1995
10 "Non-genomic action of the mineralocorticoid aldosterone on cytosolic sodium in cultured kidney cells" 511 : 255-263, 1998
11 "Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism" 29 : 723-727, 1997
12 "Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1" 149-156, 1992
13 "Epithelial sodium channel regulated by aldosterone induced protein sgk" 96 : 2514-2519, 1999
14 "Disorders of the renin angiotensin-aldosterone system" Boston, Little Brown 349-392, 1997
15 "Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121" 877-885, 1994
16 "Determinants of cardiac fibrosis in experimental hypermineralocorticoid states" 269 : E657-E662, 1995
17 "Comparison of Target Organ Damages between Primary Aldosteronism and Essential Hypertension" 22 : 11-18, 2007
18 "Cardiac damage prevention by eplereonone: comparison with low sodium diet or potassium loading" 39 : 614-618, 2002
19 "Associations between circulating components of the renin-angiotensin -aldosterone system and left ventricular mass" 77 : 24-31, 1997
20 "Association of hypokalemia" 345-351, 1990
21 "Androsterone upregulates Ca2+ current in adult rat cardiomyocytes" 85 : 1139-1145, 1999
22 "Aldosterone: a mediator of myocardial necrosis and renal arteriopathy" 141 : 3871-3878, 2000